Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Nat Commun ; 6: 8480, 2015 Sep 28.
Article in English | MEDLINE | ID: mdl-26412387

ABSTRACT

Optogenetics has provided a revolutionary approach to dissecting biological phenomena. However, the generation and use of optically active GPCRs in these contexts is limited and it is unclear how well an opsin-chimera GPCR might mimic endogenous receptor activity. Here we show that a chimeric rhodopsin/ß2 adrenergic receptor (opto-ß2AR) is similar in dynamics to endogenous ß2AR in terms of: cAMP generation, MAP kinase activation and receptor internalization. In addition, we develop and characterize a novel toolset of optically active, functionally selective GPCRs that can bias intracellular signalling cascades towards either G-protein or arrestin-mediated cAMP and MAP kinase pathways. Finally, we show how photoactivation of opto-ß2AR in vivo modulates neuronal activity and induces anxiety-like behavioural states in both fiber-tethered and wireless, freely moving animals when expressed in brain regions known to contain ß2ARs. These new GPCR approaches enhance the utility of optogenetics and allow for discrete spatiotemporal control of GPCR signalling in vitro and in vivo.


Subject(s)
Optogenetics , beta-Adrenergic Receptor Kinases/metabolism , Animals , Anxiety/enzymology , Cyclic AMP/metabolism , HEK293 Cells , Humans , Male , Mice, Inbred C57BL , Mitogen-Activated Protein Kinases/metabolism
2.
Neuron ; 86(4): 923-935, 2015 May 20.
Article in English | MEDLINE | ID: mdl-25937173

ABSTRACT

Optogenetics is now a widely accepted tool for spatiotemporal manipulation of neuronal activity. However, a majority of optogenetic approaches use binary on/off control schemes. Here, we extend the optogenetic toolset by developing a neuromodulatory approach using a rationale-based design to generate a Gi-coupled, optically sensitive, mu-opioid-like receptor, which we term opto-MOR. We demonstrate that opto-MOR engages canonical mu-opioid signaling through inhibition of adenylyl cyclase, activation of MAPK and G protein-gated inward rectifying potassium (GIRK) channels and internalizes with kinetics similar to that of the mu-opioid receptor. To assess in vivo utility, we expressed a Cre-dependent viral opto-MOR in RMTg/VTA GABAergic neurons, which led to a real-time place preference. In contrast, expression of opto-MOR in GABAergic neurons of the ventral pallidum hedonic cold spot led to real-time place aversion. This tool has generalizable application for spatiotemporal control of opioid signaling and, furthermore, can be used broadly for mimicking endogenous neuronal inhibition pathways.


Subject(s)
Analgesics, Opioid/pharmacology , Behavior, Animal/drug effects , GABAergic Neurons/drug effects , Optogenetics , Receptors, Opioid, mu/metabolism , Signal Transduction/drug effects , Animals , Cells, Cultured , GABAergic Neurons/metabolism , Rats , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/physiology
SELECTION OF CITATIONS
SEARCH DETAIL